Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 11.42%56.93B | 9.77%213.37B | 6.60%49.57B | 9.62%54.19B | 13.34%58.52B | 9.16%51.09B | 7.24%194.37B | 9.20%46.5B | 9.27%49.44B | 5.67%51.63B |
Cost of revenue | 11.93%33.37B | 7.61%126.68B | 5.25%30.8B | 5.02%32.4B | 10.77%33.67B | 9.55%29.82B | 11.66%117.72B | 11.03%29.26B | 15.67%30.85B | 10.35%30.4B |
Gross profit | 10.71%23.56B | 13.10%86.69B | 8.89%18.77B | 17.23%21.79B | 17.01%24.85B | 8.63%21.28B | 1.09%76.65B | 6.20%17.24B | 0.08%18.59B | -0.38%21.24B |
Operating expense | 8.66%16.81B | 8.14%66.42B | 15.46%18.19B | 7.96%16.27B | 5.37%16.48B | 3.52%15.47B | 5.63%61.42B | -0.48%15.76B | 4.08%15.07B | 8.77%15.64B |
Operating profit | 16.16%6.74B | 33.06%20.27B | -60.88%581M | 56.93%5.52B | 49.60%8.36B | 25.09%5.8B | -13.85%15.24B | 268.49%1.49B | -14.04%3.52B | -19.36%5.59B |
Net non-operating interest income (expenses) | 52.17%-11M | 13.64%-76M | 84.29%-11M | -175.00%-22M | -400.00%-20M | -283.33%-23M | -576.92%-88M | -1,300.00%-70M | -166.67%-8M | 20.00%-4M |
Non-operating interest income | 650.00%15M | 52.63%29M | 114.29%15M | 0.00%5M | 40.00%7M | 0.00%2M | -9.52%19M | 75.00%7M | 0.00%5M | 25.00%5M |
Non-operating interest expense | 4.00%26M | 87.50%105M | 0.00%26M | 107.69%27M | 200.00%27M | 212.50%25M | 64.71%56M | 188.89%26M | 62.50%13M | 0.00%9M |
Total other finance cost | ---- | ---- | ---- | ---- | ---- | ---- | --51M | ---- | ---- | ---- |
Net investment income | 15.25%204M | 10.37%298M | -33.33%8M | 23.81%104M | 28.57%9M | 5.99%177M | -50.28%270M | 20.00%12M | 13.51%84M | 16.67%7M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -76.92%30M | 185.40%782M | 0 | 643M | 9M | -52.38%130M | -98.75%274M | -100.00%1M | 0 | 0 |
Income from associates and other participating interests | -1,666.67%-47M | 0 | -225.00%-5M | 400.00%5M | -250.00%-3M | 200.00%3M | 116.00%4M | 157.14%4M | -50.00%1M | 150.00%2M |
Special income (charges) | 39.86%-83M | 42.50%-1.28B | 122.26%120M | -288.66%-1.3B | 103.09%36M | 28.50%-138M | -103.93%-2.23B | 19.67%-539M | -89.27%-335M | -1,153.76%-1.17B |
Less:Impairment of capital assets | -66.67%4M | -54.12%39M | -63.64%8M | -63.64%8M | -45.00%11M | -42.86%12M | -24.11%85M | -15.38%22M | -21.43%22M | -31.03%20M |
Less:Other special charges | -37.30%79M | -131.15%-467M | -147.19%-235M | -199.36%-311M | -109.11%-47M | -26.74%126M | 69.57%1.5B | -8.79%498M | 110.07%313M | 706.25%516M |
Less:Write off | ---- | 163.79%1.71B | 463.16%107M | ---- | ---- | ---- | 555.56%649M | -80.81%19M | --0 | ---- |
Other non-operating income (expenses) | 52.78%55M | 38.15%583M | -15.82%298M | 325.97%174M | -22.68%75M | -25.00%36M | 146.78%422M | 2,428.57%354M | -450.00%-77M | 56.45%97M |
Income before tax | 15.04%6.89B | 48.20%20.58B | -20.37%993M | 60.99%5.13B | 87.06%8.47B | 21.58%5.99B | -64.60%13.88B | -94.25%1.25B | -20.68%3.18B | -34.38%4.53B |
Income tax | 21.50%1.96B | 44.75%5.2B | -795.65%-206M | 59.00%1.33B | 87.14%2.46B | 10.32%1.61B | -68.08%3.59B | -100.36%-23M | -17.09%839M | -38.31%1.31B |
Net income | 12.67%4.93B | 49.39%15.37B | -5.66%1.2B | 61.73%3.79B | 87.05%6.01B | 26.31%4.37B | -63.19%10.29B | -91.69%1.27B | -21.89%2.34B | -32.64%3.21B |
Net income continuous operations | 12.66%4.93B | 49.40%15.38B | -5.59%1.2B | 61.71%3.79B | 87.02%6.01B | 26.34%4.38B | -63.19%10.29B | -91.70%1.27B | -21.89%2.35B | -32.63%3.21B |
Noncontrolling interests | -9.62%47M | -4.76%220M | -56.52%30M | -5.63%67M | 91.89%71M | -3.70%52M | 24.19%231M | 97.14%69M | 136.67%71M | -35.09%37M |
Net income attributable to the company | 12.91%4.88B | 50.65%15.15B | -2.75%1.17B | 63.88%3.73B | 86.96%5.94B | 26.82%4.32B | -63.78%10.06B | -92.12%1.2B | -23.49%2.27B | -32.63%3.18B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 12.91%4.88B | 50.65%15.15B | -2.75%1.17B | 63.88%3.73B | 86.96%5.94B | 26.82%4.32B | -63.78%10.06B | -92.12%1.2B | -23.49%2.27B | -32.63%3.18B |
Gross dividend payment | ||||||||||
Basic earnings per share | 16.20%54.24 | 58.65%165.6 | 2.00%13.27 | 71.36%41.05 | 97.04%64.6 | 34.80%46.68 | -62.22%104.38 | -91.43%13.01 | -18.93%23.955 | -30.03%32.785 |
Diluted earnings per share | 16.20%54.24 | 58.65%165.6 | 1.09%12.9016 | 72.56%41.05 | 97.04%64.6 | 34.80%46.68 | -62.22%104.38 | -91.60%12.7627 | -19.49%23.7885 | -30.03%32.785 |
Dividend per share | 0 | 10.00%55 | 10.00%55 | 0 | 0 | 0 | 11.11%50 | 11.11%50 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |